SCHEMBL6274233

SCHEMBL6274233

CCC(C)CCCOc1c(O)c2ccc(OCCO)cc2oc1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT1 Q96EB6 1/20 0.43
MAP1LC3B Q9GZQ8 1/20 0.41
MAP1LC3A Q9H492 1/20 0.41
NQO1 P15559 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA9 Q16790 1/20 0.41
KDM4E B2RXH2 5/20 0.41
ALDH1A1 P00352 5/20 0.41
HPGD P15428 5/20 0.41
TSHR P16473 2/20 0.41
HSD17B10 Q99714 2/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
GAA P10253 1/20 0.41
XDH P47989 1/20 0.41
ALDH2 P05091 2/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
RAB9A P51151 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6274722 0.88 MAP1LC3B (0.51) MAP1LC3BMAP1LC3ANQO1CA12CA1
SCHEMBL6277723 0.88 AKR1C3 (0.51) SIRT1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL27599720 0.87 NQO1 (0.48) NQO1KDM4EALDH1A1HPGDTSHR
SCHEMBL6277695 0.86 ALDH2 (0.52) MAP1LC3BMAP1LC3ANQO1CA12CA1
SCHEMBL6276865 0.86 KDM4E (0.55) MAP1LC3BMAP1LC3ANQO1CA12CA1
SCHEMBL6270779 0.85 MAP1LC3B (0.43) MAP1LC3BMAP1LC3ANQO1CA12CA1
SCHEMBL6276950 0.85 ALDH2 (0.53) MAP1LC3BMAP1LC3ANQO1CA12CA1
SCHEMBL6275616 0.85 ALDH2 (0.53) MAP1LC3BMAP1LC3ANQO1CA12CA1
SCHEMBL6276949 0.85 ALDH2 (0.53) MAP1LC3BMAP1LC3ANQO1CA12CA1
SCHEMBL6275210 0.85 ALDH2 (0.53) MAP1LC3BMAP1LC3ANQO1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1273578-B1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK & CHEMICALS (JP) 2005-02-23 EP disclosed
US-6670391-B2 For inhibiting both immediate and delayed type allergic reactions; side effect reduction DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-12-30 US disclosed
US-20030096860-A1 Benzopyran derivative and antiallergic agent DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-05-22 US disclosed
EP-1273578-A1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096860-A1 Benzopyran derivative and antiallergic agent HRH2, HRH1, HRH4 SIRT1 623/4885MAP1LC3B 4772/4885MAP1LC3A 4614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.